News
Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.
Pfizer Inc. announced that it has combined operations with King Pharmaceuticals, Inc. On February 28, 2011, Pfizer completed its acquisition of King through the...
Press Releases
Apricus Biosciences Announced European Patient Coverage For Mycova For Nail Fungus
Apricus Biosciences, Inc. announced that the European Patent Office will grant a patent for the company's MycoVa™ product for treating onychomycosis (commonly referred to...
Press Releases
Trophos successfully completes phase 1 study for novel cardioprotective compound, TRO40303
Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology,...
Press Releases
Novartis gains positive CHMP opinion for Rasilamlo(TM), a single-pill combination of aliskiren and amlodipine to treat high blood pressure
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Rasilamlo(TM) (aliskiren and amlodipine) to treat high...
News
Pharma Idol Winner Announced
Since launching in November, eyeforpharma's Pharma Idol competition has caused quite a stir in the industry and not just due to the launch video...
Research Insight
Progenics Reports Positive Preliminary Data from Ongoing Phase 1 Clinical Study of PSMA ADC
Progenics Pharmaceuticals, Inc.reported positive preliminary data from an ongoing phase 1 study of PSMA ADC, an antibody-drug conjugate (ADC) designed to selectively deliver chemotherapy...
Press Releases
CIT and Stemina Biomarker Discovery announce partnership in Europe for stem cell based toxicology testing
CIT – Safety and Health Research Laboratories and Stemina Biomarker Discovery, Inc. announced that CIT and Stemina have entered into a strategic partnership. Under...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read